$RX.V $BIOYF Downtrend ending, with good Q2 ER.

Really good Q2 with some nice growth. If order was not delayed, y/y growth would've been 38% now it's around 17%, but still the order is shipped so it'll have a big impact on Q3.

Technically speaking, I think it will bust out of downtrend soon enough with big bid support around 6,30$